All Reports Events Blogs Videos
Showing 9 results
  • Tech Launch Perspective
    July 22, 2026

    Life sciences enterprises are moving beyond isolated generative AI pilots toward governed, multi-agent workflows that support clinical, commercial, and real-world activities. This shift is increasing demand for platforms that combine regulatory-grade data governance, enterprise interoperability, scalable…
  • Provider Recognition
    July 15, 2026

    Pharmaceutical enterprises are accelerating technology investments to modernize operations across the pharmaceutical value chain spanning drug discovery, clinical development, manufacturing, sales and marketing, supply chain and distribution, and pharmacovigilance. As AI, cloud, and data-driven capabilities become…
  • Blog
    July 14, 2026

    Life Sciences commercial teams have a familiar problem: every few years, the industry finds a new way to create fragmentation.  First came Customer Relationship Management (CRM) add-ons. Then omnichannel tools, content platforms, analytics dashboards, field enablement systems, event platforms,…
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • Viewpoint
    Aug. 20, 2025

    AI’s rapid evolution is revolutionizing the life sciences sector. After significant generative AI-enabled advances, enterprises are now witnessing the rise of agentic AI – autonomous systems capable of independent decision-making and action execution. However, many life…
  • Blog
    Oct. 24, 2024

    Remember when we were all buzzing about the metaverse like it was going to redefine reality? Yeah, that was just two years ago!Fast forward to last year, and suddenly generative AI  (gen AI) has become the…